Study at a glance
What did studies examine about vitamin D and depression?
A small trial tested vitamin D3 against placebo in adults with mild or moderate depression. A separate population study examined links among childhood abuse history, vitamin D status, genetic differences and depression. The trial tested a treatment; the population study observed existing differences. They did not prove one complete biological pathway.
Did vitamin D improve depression scores in the trial?
After eight weeks, average depression scores improved more with vitamin D than with placebo. The reported results included 28 people per group, mostly women, and most were not severely vitamin D deficient. However, the flow diagram showed 69 people assigned to treatment, while the text described 56. Missing results were not clearly explained. Average score improvement did not establish how many people recovered, and depression was an additional outcome rather than the trial’s main outcome.
Did the studies explain how vitamin D might affect depression?
Three measured blood signs of inflammation did not show significant treatment effects. This did not rule out every inflammatory process. The trial did not measure brain serotonin or stress-hormone function. In the population study, an exploratory pattern involved current symptoms, abuse history, vitamin D status and groups based on genetic differences. The corresponding analysis of lifetime depression did not show a significant result, and some statistics were reported inconsistently.
Do these findings establish a supplement plan for depression?
A genetic marker used in another analysis was a weak substitute for measured vitamin D, and confirmation was incomplete. These associations do not show that supplements help or establish treatment based on someone’s genes. Together, the studies suggest questions for further research. They do not prove that vitamin D prevents depression after childhood adversity or establish a general depression treatment or a plan for taking supplements.
Read the full article below ↓Two different studies address vitamin D and mood from different directions. A small trial reported greater depression-score improvement without significant changes in three inflammatory markers. A population study found exploratory interactions involving abuse history, status and genetics. These results cannot be joined into one proven biological pathway. For the detailed analysis, see Vitamin D, Depression Symptoms and Stress-Related Risk Patterns: Full Study.
This is a VD3FL analysis, not either original publication. The two principal papers, the Bonk supplement and the Kaviani protocol and registry were reviewed. The studies used different people, designs and outcomes.
The trial result
Kaviani and colleagues studied an eight-week regimen of 50,000 IU cholecalciferol every two weeks versus placebo in adults with mild or moderate depression. This was a research regimen, not advice to self-treat. The outcome tables included 28 people per arm, mostly women, and baseline status was not predominantly severely deficient.
Mean depression-score changes were -11.75 points with vitamin D and -3.61 with control. Their difference is 8.14 points, calculated from the published means. The report did not supply a confidence interval for that calculated change difference. Average improvement does not establish individual remission.
The flow diagram shows 69 randomised, whereas the text describes 56; only 56 appear in the outcome tables. The paper does not clearly explain missing-data handling for everyone randomised. This weakens confidence in how the result represents the full trial population.
The inflammatory explanation was not demonstrated
Interleukin-1 beta, interleukin-6 and high-sensitivity C-reactive protein did not show significant treatment effects. Those results are relevant to Vitamin D and Inflammatory Signalling, but they do not exclude every inflammatory mechanism or show a formally tested absence of mediation.
The trial did not measure cortisol, stress-axis function or brain serotonin. It was registered after its stated start, and depression was a secondary outcome. Its findings contribute to Vitamin D and Mood without establishing that supplements treat depression generally.
The observational study
Bonk and colleagues analysed two German population cohorts. Genetic and phenotype analyses involved 4,936 people in total, but measured vitamin D was available for 2,901 participants in one cohort. Abuse history was recalled retrospectively; current symptoms and lifetime depression were different outcomes.
A three-way interaction for current symptoms involving measured status, a serotonin-transporter genetic grouping and abuse history had P=.043. Its confidence interval was printed inconsistently between the narrative and table. The corresponding measured-status interaction for lifetime depression was null, P=.951.
A separate genetic-proxy analysis produced different results. The proxy explained only 0.25% of measured status variation, and one replication had a two-sided P=.088. These findings do not establish a supplement effect or a genotype-based treatment rule. The broader topic of Vitamin D and Stress Physiology needs this distinction between reported stress exposure and directly measured physiological responses.
Conclusion
The trial offers a symptom-improvement signal with reporting limitations and selected inflammatory null results. The population study offers exploratory, outcome-specific associations. Neither demonstrates that vitamin D prevents depression after childhood adversity or proves a complete stress-to-inflammation-to-serotonin mechanism.
Scientific sources
Kaviani M, et al. Effects of vitamin D supplementation on depression and some selected pro-inflammatory biomarkers: a double-blind randomized clinical trial. BMC Psychiatry. 2022;22:694. DOI 10.1186/s12888-022-04305-3; PMID 36368945.
Bonk S, Hertel J, Zacharias HU, et al. Vitamin D moderates the interaction between 5-HTTLPR and childhood abuse in depressive disorders. Scientific Reports. 2020;10:22394. DOI 10.1038/s41598-020-79388-7; PMID 33372187.
ClinicalTrials.gov. Vitamin D Supplementation in Patients With Depression. Trial registration, NCT03766074; current record, not a separate trial.
Related reading
Comparative Analysis of Dietary Patterns in Children With Phenylketonuria Phenotypes and Controls: Implications for Nutritional Status
This study evaluated dietary patterns and physical activity levels in children with different PKU phenotypes compared to healthy controls.
Original paper ↗Read more →Complementary feeding patterns of Filipino infants and toddlers lack diversity, especially among children from poor households
The aim of this study was to describe the food and beverage consumption patterns among 6 to 23.9 month old Filipino infants and toddlers, by household wealth.
Original paper ↗Read more →Factors Associated with Dual-Fluency Walk Speed Improvement after Rehabilitation in Older Patients
Our objective was to investigate the association between geriatric factors and an increase in dual-task walk speed (threshold of 0.1 m/s), after a multidisciplinary rehabilitation program.
Original paper ↗Read more →Identifying patterns to uncover the importance of biological pathways on known drug repurposing scenarios
In this article, we investigated the use of biological pathways as potential elements to achieve effective drug repurposing.
Original paper ↗Read more →Nutrient Intake, Diet Quality, and Weight Measures in Breakfast Patterns Consumed by Children Compared with Breakfast Skippers: NHANES 2001 to 2008
The purpose of this study was to classify breakfast meals into patterns and determine the association of the breakfast patterns with daily and breakfast nutrient intakes, diet quality, and weight.
Original paper ↗Read more →Relationship between Serum 25(OH)D and Depression: Causal Evidence from a Bi-Directional Mendelian Randomization Study
The relationship between depression and vitamin D deficiency is complex, with evidence mostly from studies affected by confounding and reverse causality.
Original paper ↗Read more →The Impact of the Dietary Intake of Vitamin B12, Folic Acid, and Vitamin D3 on Homocysteine Levels and the Health-Related Quality of Life of Levodopa-Treated Patients with Parkinson’s Disease: A Pilot Study in Romania
Background and Objectives: Previous studies have shown that the levodopa treatment of Parkinson’s disease (PD) elevates circulating homocysteine levels, which are associated with an increased risk of cardiovascular and neurological disorders, or thrombosis.
Original paper ↗Read more →Effects of vitamin D supplementation on depression and some selected pro-inflammatory biomarkers: a double-blind randomized clinical trial
An 8-week double-blind randomized clinical trial (RCT) was performed on 56 (18 to 60 yrs) patients with mild to moderate depression, randomly assigned to intervention (50,000 IU cholecalciferol 2wks−1) and control (placebo) groups.
Original paper ↗Read more →Vitamin D moderates the interaction between 5-HTTLPR and childhood abuse in depressive disorders
A complex interplay between genetic and environmental factors determines the individual risk of depressive disorders.
Original paper ↗Read more →Does inflammation moderate the effect of vitamin D supplementation on depressive symptoms? Results of an interventional study in children and adolescents
In the first randomized controlled trial (RCT) in depressed, vitamin D-deficient adolescents (DRKS00009758), symptom reduction emerged in only one of three outcomes.
Original paper ↗Read more →Does inflammation moderate the effect of vitamin D supplementation on depressive symptoms? Results of an interventional study in children and adolescents
These analyses aimed to determine whether treatment effects on depressive symptoms significantly differed depending on baseline CRP levels.
Original paper ↗Read more →Association of Vitamin D Supplementation with Glutathione Peroxidase (GPx) Activity, Interleukine-6 (IL-6) Levels, and Anxiety and Depression Scores in Patients with Post-COVID-19 Condition
We conducted a self-controlled study in which 54 participants with PCC were supplemented with vitamin D3 (n = 28 bolus and n = 26 daily) for 2 months.
Original paper ↗Read more →Metabolic Syndrome, Inflammation, Oxidative Stress, and Vitamin D Levels in Children and Adolescents with Obesity
Our aim was to determine whether vitamin D mediates inflammation and oxidative stress, assessed through selected biomarkers, in children with obesity and/or MetS.
Original paper ↗Read more →Intact FGF23 and Markers of Iron Homeostasis, Inflammation, and Bone Mineral Metabolism in Acute Pediatric Infections
The aim of this prospective clinical study is to evaluate the association of i-FGF23 with hepcidin and markers of iron homeostasis, erythropoiesis, inflammation, and bone mineral metabolism in acute pediatric infections.
Original paper ↗Read more →Integrative analysis of vitamin D, ferritin, and eosinophilic inflammation in predicting acute exacerbations of childhood asthma
This study investigated the associations of serum vitamin D, ferritin, and eosinophilic inflammation with acute asthma exacerbations in children and explored their potential interaction.
Original paper ↗Read more →Longitudinal associations between vitamin D status and biomarkers of inflammation in a pan-European cohort of children and adolescents
To investigate longitudinal associations between the vitamin D status and inflammatory markers in children and adolescents.
Original paper ↗Read more →The association of Malnutrition-Inflammation Score with sleep quality and mental health in hemodialysis patients: a multicenter cross-sectional study
Therefore, the study aimed to investigate the association between the Malnutrition-Inflammation Score (MIS) and various health parameters, including sleep quality and mental health in hemodialysis patients.
Original paper ↗Read more →The impact of a needs-oriented dental prophylaxis program on bacteremia after toothbrushing and systemic inflammation in children, adolescents, and young adults with chronic kidney disease
General prevalence of bacteremia after toothbrushing was 9.5% affecting 7 (26%) of the participants.
Original paper ↗Read more →Vitamin D, Depression Symptoms and Stress-Related Risk Patterns: Full Study
Analysis of a depression trial and a population study on vitamin D and stress-related risk, keeping symptom findings, inflammatory markers and associations distinct.
Read more →Effect of low energy diet for eight weeks to adults with overweight or obesity on folate, retinol, vitamin B12, D and E status and the degree of inflammation: a post hoc analysis of a randomized intervention trial
The purpose of this study was to investigate the effect of weight loss on folate, retinol, vitamin B12, D and E status and the degree of inflammation.
Original paper ↗Read more →Vitamin D and inflammatory markers: cross-sectional analyses using data from the English Longitudinal Study of Ageing (ELSA)
Our findings showed that 25(OH)D levels were associated with two out the three inflammatory markers investigated.
Original paper ↗Read more →Original sources
Effects of vitamin D supplementation on depression and some selected pro-inflammatory biomarkers: a double-blind randomized clinical trial
Published in BMC Psychiatry (2022).
Publication details
Kaviani M, et al. Effects of vitamin D supplementation on depression and some selected pro-inflammatory biomarkers: a double-blind randomized clinical trial. BMC Psychiatry. 2022;22:694. DOI 10.1186/s12888-022-04305-3; PMID 36368945.
Vitamin D moderates the interaction between 5-HTTLPR and childhood abuse in depressive disorders
Published in Scientific Reports (2020).
Publication details
Bonk S, Hertel J, Zacharias HU, et al. Vitamin D moderates the interaction between 5-HTTLPR and childhood abuse in depressive disorders. Scientific Reports. 2020;10:22394. DOI 10.1038/s41598-020-79388-7; PMID 33372187.
Vitamin D Supplementation in Patients With Depression
ClinicalTrials.gov. Vitamin D Supplementation in Patients With Depression.
Publication details
ClinicalTrials.gov. Vitamin D Supplementation in Patients With Depression. Trial registration, NCT03766074; current record, not a separate trial.